TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Cross-over Trial in the Effect of Automated Oxygen Control Devices on the Distribution of Oxygen Saturation in Preterm Infants
Brief Summary: Premature infants often receive respiratory support and supplemental oxygen for a prolonged period of time during their admission in the NICU. While maintaining the oxygen saturation within a narrow target range is important to prevent morbidity, manual oxygen titration can be very challenging. Automatic titration by a controller has been proven to be more effective. However, to date the performance of different controllers has not been compared. The proposed randomized crossover trial Comparing Oxygen Controllers in Preterm InfanTs (COCkPIT) is designed to compare the effect on time spent within target range. The results of this trial will help determining which algorithm is most successful in controlling oxygen, improve future developments in automated oxygen control and ultimately reduce the morbidity associated with hypoxemia and hyperoxemia.


Options:
A: Arm Label: Automated FiO2 control; Type: EXPERIMENTAL; Interventions: Device: Automated FiO2 Control | Arm Label: Manual Adjustment; Type: PLACEBO_COMPARATOR; Interventions: N/A | Intervention Type: DEVICE; Name: Automated FiO2 Control; Assigned to Arm(s): Automated FiO2 control
B: Arm Label: IntellO2; Type: EXPERIMENTAL; Interventions: Device: IntellO2 | Arm Label: Manual; Type: ACTIVE_COMPARATOR; Interventions: Other: Manual control | Intervention Type: DEVICE; Name: IntellO2; Assigned to Arm(s): IntellO2 | Intervention Type: OTHER; Name: Manual control; Assigned to Arm(s): Manual
C: Arm Label: CLiO2; Type: EXPERIMENTAL; Interventions: Device: Automated oxygen control by the CLiO2 algorithm | Arm Label: Oxygenie; Type: EXPERIMENTAL; Interventions: Device: Automated oxygen control by the Oxygenie algorithm | Intervention Type: DEVICE; Name: Automated oxygen control by the CLiO2 algorithm; Assigned to Arm(s): CLiO2 | Intervention Type: DEVICE; Name: Automated oxygen control by the Oxygenie algorithm; Assigned to Arm(s): Oxygenie
D: Arm Label: Manual oxygen control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Closed-loop automated oxygen control; Type: OTHER; Interventions: Device: Closed-loop automated oxygen control (Oxygenie, SLE 6000) | Intervention Type: DEVICE; Name: Closed-loop automated oxygen control (Oxygenie, SLE 6000); Assigned to Arm(s): Closed-loop automated oxygen control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Happy Mother-Healthy Baby: An Anxiety-focused Early Prenatal Intervention for the Prevention of Common Mental Disorders in Pakistan
Brief Summary: In the proposed study the investigators will develop an early prenatal preventive intervention targeting anxiety and conduct a randomized controlled trial in Pakistan to test its efficacy in reducing generalized anxiety disorder and major depression in mothers in late pregnancy and the postnatal period. Investigators will evaluate the impact of the intervention on fetal and infant growth restriction as well as examine how the impact of the intervention is mediated (to elucidate mechanisms) and/or modified (to help optimize future adaptations of the program) by various social factors. A cost-effectiveness evaluation will shed light on the costs and benefits of intervention components in relation to outcomes, enabling policy-makers and public health planners to scale up this intervention according to resource budgeting requirements.


Options:
A: Arm Label: Footlength Card; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Footlength Card | Arm Label: No Footlength Card; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Footlength Card; Assigned to Arm(s): Footlength Card
B: Arm Label: Cognitive Behavioral Therapy Intervention for Anxiety; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy Intervention for Anxiety | Arm Label: Enhanced Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy Intervention for Anxiety; Assigned to Arm(s): Cognitive Behavioral Therapy Intervention for Anxiety
C: Arm Label: Postpartum Visit 3-4 Weeks; Type: EXPERIMENTAL; Interventions: Behavioral: Postpartum Visit 3-4 Weeks | Arm Label: Postpartum Visit 6-8 Weeks; Type: EXPERIMENTAL; Interventions: Behavioral: Postpartum Visit 6-8 Weeks | Intervention Type: BEHAVIORAL; Name: Postpartum Visit 3-4 Weeks; Assigned to Arm(s): Postpartum Visit 3-4 Weeks | Intervention Type: BEHAVIORAL; Name: Postpartum Visit 6-8 Weeks; Assigned to Arm(s): Postpartum Visit 6-8 Weeks
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Relaxation; Type: EXPERIMENTAL; Interventions: Behavioral: Relaxation | Intervention Type: BEHAVIORAL; Name: Relaxation; Assigned to Arm(s): Relaxation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Happy Mother-Healthy Baby: An Anxiety-focused Early Prenatal Intervention for the Prevention of Common Mental Disorders in Pakistan
Brief Summary: In the proposed study the investigators will develop an early prenatal preventive intervention targeting anxiety and conduct a randomized controlled trial in Pakistan to test its efficacy in reducing generalized anxiety disorder and major depression in mothers in late pregnancy and the postnatal period. Investigators will evaluate the impact of the intervention on fetal and infant growth restriction as well as examine how the impact of the intervention is mediated (to elucidate mechanisms) and/or modified (to help optimize future adaptations of the program) by various social factors. A cost-effectiveness evaluation will shed light on the costs and benefits of intervention components in relation to outcomes, enabling policy-makers and public health planners to scale up this intervention according to resource budgeting requirements.


Options:
A: Arm Label: Mother Touch Program; Type: EXPERIMENTAL; Interventions: Other: Mothers Touch Program | Arm Label: Usual care Program; Type: OTHER; Interventions: Other: Usual Care Program | Intervention Type: OTHER; Name: Mothers Touch Program; Assigned to Arm(s): Mother Touch Program | Intervention Type: OTHER; Name: Usual Care Program; Assigned to Arm(s): Usual care Program
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: RLPT | Intervention Type: BEHAVIORAL; Name: RLPT; Assigned to Arm(s): Intervention
C: Arm Label: Philani Intervention Program; Type: EXPERIMENTAL; Interventions: Behavioral: Philani Intervention Program | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Philani Intervention Program; Assigned to Arm(s): Philani Intervention Program
D: Arm Label: Cognitive Behavioral Therapy Intervention for Anxiety; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy Intervention for Anxiety | Arm Label: Enhanced Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy Intervention for Anxiety; Assigned to Arm(s): Cognitive Behavioral Therapy Intervention for Anxiety

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Happy Mother-Healthy Baby: An Anxiety-focused Early Prenatal Intervention for the Prevention of Common Mental Disorders in Pakistan
Brief Summary: In the proposed study the investigators will develop an early prenatal preventive intervention targeting anxiety and conduct a randomized controlled trial in Pakistan to test its efficacy in reducing generalized anxiety disorder and major depression in mothers in late pregnancy and the postnatal period. Investigators will evaluate the impact of the intervention on fetal and infant growth restriction as well as examine how the impact of the intervention is mediated (to elucidate mechanisms) and/or modified (to help optimize future adaptations of the program) by various social factors. A cost-effectiveness evaluation will shed light on the costs and benefits of intervention components in relation to outcomes, enabling policy-makers and public health planners to scale up this intervention according to resource budgeting requirements.


Options:
A: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Current collaborative care protocol | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Training in management of children's mental health problems | Intervention Type: OTHER; Name: Training in management of children's mental health problems; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Current collaborative care protocol; Assigned to Arm(s): Control
B: Arm Label: Cognitive Behavioral Therapy Intervention for Anxiety; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy Intervention for Anxiety | Arm Label: Enhanced Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy Intervention for Anxiety; Assigned to Arm(s): Cognitive Behavioral Therapy Intervention for Anxiety
C: Arm Label: Self Help Plus; Type: EXPERIMENTAL; Interventions: Behavioral: Self Help Plus | Arm Label: Enhanced Treatment As Usual; Type: OTHER; Interventions: Other: Enhanced Treatment As Usual | Intervention Type: BEHAVIORAL; Name: Self Help Plus; Assigned to Arm(s): Self Help Plus | Intervention Type: OTHER; Name: Enhanced Treatment As Usual; Assigned to Arm(s): Enhanced Treatment As Usual
D: Arm Label: Waitlist-Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Common Elements Treatment Approach; Type: EXPERIMENTAL; Interventions: Behavioral: Common Elements Treatment Approach | Intervention Type: BEHAVIORAL; Name: Common Elements Treatment Approach; Assigned to Arm(s): Common Elements Treatment Approach

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Advanced REperfusion STrategies for Refractory Cardiac Arrest (The ARREST Trial)
Brief Summary: This is a Phase II, single center (Under the Center for Resuscitation Medicine at the University of Minnesota Medical School), partially blinded, prospective, intention to treat, safety and efficacy clinical trial, randomizing adult patients (18-75 years old) with refractory ventricular fibrillation/pulseless ventricular tachycardia (VF/VT) out-of hospital cardiac arrest (OHCA) who are transferred by emergency medical services (EMS) with ongoing mechanical cardiopulmonary resuscitation (CPR) or who are resuscitated to receive one of the 2 local standards of care practiced in our community: 1) Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation or 2) Standard Advanced Cardiac Life Support (ACLS) Resuscitation


Options:
A: Arm Label: ECMO arm; Type: EXPERIMENTAL; Interventions: Device: ECMO (Quadrox®, Jostra®, Maquet®) | Arm Label: conventional arm; Type: ACTIVE_COMPARATOR; Interventions: Other: conventional care | Intervention Type: DEVICE; Name: ECMO (Quadrox®, Jostra®, Maquet®); Assigned to Arm(s): ECMO arm | Intervention Type: OTHER; Name: conventional care; Assigned to Arm(s): conventional arm
B: Arm Label: Intensive care survivors; Type: N/A; Interventions: N/A
C: Arm Label: CCPR protocol; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: ECPR protocol; Type: EXPERIMENTAL; Interventions: Procedure: Extracorporeal cardiopulmonary resuscitation (ECPR) | Intervention Type: PROCEDURE; Name: Extracorporeal cardiopulmonary resuscitation (ECPR); Assigned to Arm(s): ECPR protocol
D: Arm Label: ECMO Facilitated Resuscitation; Type: EXPERIMENTAL; Interventions: Device: Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation | Arm Label: Standard ACLS Resuscitation; Type: OTHER; Interventions: Device: Standard Advanced Cardiac Life Support (ACLS) Resuscitation | Intervention Type: DEVICE; Name: Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation; Assigned to Arm(s): ECMO Facilitated Resuscitation | Intervention Type: DEVICE; Name: Standard Advanced Cardiac Life Support (ACLS) Resuscitation; Assigned to Arm(s): Standard ACLS Resuscitation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of a Hybrid Cardiac Rehabilitation Program for Coronary Artery Disease Patients. Randomized, Multicenter, Non-inferiority Clinical Trial in a Low-resource Setting. HYCARET Study
Brief Summary: This clinical trial aim to evaluate if the prevention of recurrent cardiovascular events is not inferior in the hybrid mobile and exercise-based cardiac rehabilitation programs in comparison to the standard cardiac rehabilitation program.


Options:
A: Arm Label: Family-Centered Empowerment Model; Type: EXPERIMENTAL; Interventions: Other: Family-centered empowerment model | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Control | Intervention Type: OTHER; Name: Family-centered empowerment model; Assigned to Arm(s): Family-Centered Empowerment Model | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
B: Intervention Type: OTHER; Name: Peer Support; Assigned to Arm(s): N/A
C: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: HITCM+CP | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: HITCM only | Intervention Type: BEHAVIORAL; Name: HITCM+CP; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: HITCM only; Assigned to Arm(s): Arm 2
D: Arm Label: Hybrid Cardiac Rehabilitation; Type: EXPERIMENTAL; Interventions: Other: Comprehensive assessment, Other: Counseling, Other: Exercise sessions in hybrid program, Other: Transition to unsupervised phase | Arm Label: Standard Cardiac Rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Other: Comprehensive assessment, Other: Group education, Other: Exercise sessions in standard program | Intervention Type: OTHER; Name: Comprehensive assessment; Assigned to Arm(s): Hybrid Cardiac Rehabilitation, Standard Cardiac Rehabilitation | Intervention Type: OTHER; Name: Counseling; Assigned to Arm(s): Hybrid Cardiac Rehabilitation | Intervention Type: OTHER; Name: Group education; Assigned to Arm(s): Standard Cardiac Rehabilitation | Intervention Type: OTHER; Name: Exercise sessions in hybrid program; Assigned to Arm(s): Hybrid Cardiac Rehabilitation | Intervention Type: OTHER; Name: Exercise sessions in standard program; Assigned to Arm(s): Standard Cardiac Rehabilitation | Intervention Type: OTHER; Name: Transition to unsupervised phase; Assigned to Arm(s): Hybrid Cardiac Rehabilitation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Sí Texas: Improving Access to Integrated Care for Rio Grande Valley Residents With Severe & Persistent Mental Illness
Brief Summary: This study evaluated whether patients with severe and persistent mental illness (SPMI) who received coordinated co-located behavioral health and primary care services were more likely to improve health outcomes after 12 months compared to SPMI patients who receive only behavioral health services from the local mental health authority (LMHA) Tropical Texas Behavioral Health (TTBH).The study employed a randomized control trial (RCT) design where intervention participants receiving integrated behavioral health were compared to control participants receiving the usual care provided within an LMHA for SPMI patients. Patients were placed in each group using a randomized number process. Demographic and health outcome data were collected from intervention and control participants at baseline. Health outcome data was subsequently collected at 6-month and 12-month follow-up points.


Options:
A: Arm Label: Collaborative depression care; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative depression care management | Intervention Type: BEHAVIORAL; Name: Collaborative depression care management; Assigned to Arm(s): Collaborative depression care
B: Arm Label: IMPACT; Type: EXPERIMENTAL; Interventions: Other: IMPACT | Arm Label: Care as Usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: IMPACT; Assigned to Arm(s): IMPACT
C: Arm Label: Collaborative Stepped Care; Type: EXPERIMENTAL; Interventions: Other: Collaborative Stepped Care Intervention | Arm Label: Enhanced Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Enhanced Usual Care | Intervention Type: OTHER; Name: Collaborative Stepped Care Intervention; Assigned to Arm(s): Collaborative Stepped Care | Intervention Type: OTHER; Name: Enhanced Usual Care; Assigned to Arm(s): Enhanced Usual Care
D: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Reverse Colocated Integrated Care | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Reverse Colocated Integrated Care; Assigned to Arm(s): Intervention Group | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Control Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Two Types of Fixed Lingual Retainers in Preventing Mandibular Incisor Relapse
Brief Summary: The study evaluates effectiveness of two types of fixed retainers in post orthodontic patients. Half of the subjects are randomly allocated Group 1 retainer (FRC) and other half is given Group 2 retainer (MSW) and followed for a period of one year.


Options:
A: Arm Label: Fiber reinforced composite retainers; Type: EXPERIMENTAL; Interventions: Device: Orthodontic retainers | Arm Label: Multistranded stainless steel retainers; Type: EXPERIMENTAL; Interventions: Device: Orthodontic retainers | Intervention Type: DEVICE; Name: Orthodontic retainers; Assigned to Arm(s): Fiber reinforced composite retainers, Multistranded stainless steel retainers
B: Arm Label: Receive electronic reminder; Type: EXPERIMENTAL; Interventions: Other: Electronic reminder | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Electronic reminder; Assigned to Arm(s): Receive electronic reminder
C: Arm Label: Conventional; Type: EXPERIMENTAL; Interventions: Device: Vacuum Formed Thermoplastic Retainers Constructed On 3D Reconstructed Orthodontic Study Model | Arm Label: 3D; Type: EXPERIMENTAL; Interventions: Device: Vacuum Formed Thermoplastic Retainers Constructed On 3D Reconstructed Orthodontic Study Model | Intervention Type: DEVICE; Name: Vacuum Formed Thermoplastic Retainers Constructed On 3D Reconstructed Orthodontic Study Model; Assigned to Arm(s): 3D, Conventional
D: Arm Label: Thermoplastic Retainer; Type: EXPERIMENTAL; Interventions: Other: orthodontic appliance | Arm Label: Hawley Retainer; Type: ACTIVE_COMPARATOR; Interventions: Other: orthodontic appliance | Intervention Type: OTHER; Name: orthodontic appliance; Assigned to Arm(s): Hawley Retainer, Thermoplastic Retainer

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dialysis Adequacy and Clotting Complications During Anticoagulation-free Hemodialysis Using a Heparin-grafted Dialyzer and a Citrate-enriched Dialysate: a Prospective Randomized Crossover Study. (EvoCit-HD Study)
Brief Summary: After providing informed consent, patients will be randomized to either the intervention treatment ("EvoCit procedure") or the control treatment ("EvoHep procedure").

After randomization, each study arm consists of four weeks of 3x4 hours hemodialysis treatments according to the allocated protocol. After the last dialysis treatment of the fourth treatment week and after a long interdialytic interval, patients will crossover to the alternative hemodialysis procedure. After crossover, the study will be completed with, again, four weeks of 3x4 hours hemodialysis treatments according to the allocated protocol.


Options:
A: Arm Label: Tinzaparin; Type: EXPERIMENTAL; Interventions: Drug: Tinzaparin, Drug: Placebo (for Unfractionated Heparin) | Arm Label: Unfractionated Heparin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Unfractionated Heparin, Drug: Placebo (for Tinzaparin) | Intervention Type: DRUG; Name: Tinzaparin; Assigned to Arm(s): Tinzaparin | Intervention Type: DRUG; Name: Unfractionated Heparin; Assigned to Arm(s): Unfractionated Heparin | Intervention Type: DRUG; Name: Placebo (for Tinzaparin); Assigned to Arm(s): Unfractionated Heparin | Intervention Type: DRUG; Name: Placebo (for Unfractionated Heparin); Assigned to Arm(s): Tinzaparin
B: Arm Label: LMWH arm; Type: EXPERIMENTAL; Interventions: Drug: Nadroparin | Arm Label: UFH arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Unfractionated heparin | Intervention Type: DRUG; Name: Nadroparin; Assigned to Arm(s): LMWH arm | Intervention Type: DRUG; Name: Unfractionated heparin; Assigned to Arm(s): UFH arm
C: Arm Label: "EvoCit"; Type: ACTIVE_COMPARATOR; Interventions: Device: EvoCit | Arm Label: "EvoHep"; Type: ACTIVE_COMPARATOR; Interventions: Device: EvoHep | Intervention Type: DEVICE; Name: EvoCit; Assigned to Arm(s): "EvoCit" | Intervention Type: DEVICE; Name: EvoHep; Assigned to Arm(s): "EvoHep"
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: law molecular weigth heparin | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: unfractioned heparin | Intervention Type: DRUG; Name: law molecular weigth heparin; Assigned to Arm(s): A | Intervention Type: DRUG; Name: unfractioned heparin; Assigned to Arm(s): B

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Placebo-controlled Trial of ARBaclofen vs. Placebo in the Treatment of Children and Adolescents With ASD
Brief Summary: This study will examine the safety and efficacy of arbaclofen vs. placebo on social function in children and adolescents with Autism Spectrum Disorder (ASD).


Options:
A: Arm Label: Placebo for AChEI and Choline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Indistinguishable placebo tablets, matching both donepezil and choline | Arm Label: AChEI and Choline; Type: EXPERIMENTAL; Interventions: Drug: Acetyl-Choline Esterase Inhibitors and Choline supplements | Intervention Type: DRUG; Name: Acetyl-Choline Esterase Inhibitors and Choline supplements; Assigned to Arm(s): AChEI and Choline | Intervention Type: DRUG; Name: Indistinguishable placebo tablets, matching both donepezil and choline; Assigned to Arm(s): Placebo for AChEI and Choline
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: fluoxetine; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): fluoxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Arbaclofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Arbaclofen | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Arbaclofen; Assigned to Arm(s): Arbaclofen | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Sertraline Liquid Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sertraline Liquid Placebo | Arm Label: Sertraline Active Medication; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sertraline | Intervention Type: DRUG; Name: Sertraline Liquid Placebo; Assigned to Arm(s): Sertraline Liquid Placebo | Intervention Type: DRUG; Name: Sertraline; Assigned to Arm(s): Sertraline Active Medication

Answer: C